Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD
Date
2021-05-20Journal
Inflammatory Bowel DiseasesPublisher
Oxford University PressType
Article
Metadata
Show full item recordAbstract
The recent emergency use authorization of a third COVID-19 vaccine means that most patients with inflammatory bowel disease (IBD) will soon be eligible to be vaccinated. Gastroenterology clinicians should be prepared to address patients' concerns regarding safety and efficacy of vaccines. They should also strongly recommend that all their patients be vaccinated with a COVID-19 vaccine. Additionally, they should be prepared to educate patients about logistics that will result in successful vaccination completion. All these measures will be crucial to ensure high uptake among their patients with IBD. © 2021 Crohn's & Colitis Foundation.Rights/Terms
© 2021 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.Identifier to cite or link to this item
http://hdl.handle.net/10713/17250ae974a485f413a2113503eed53cd6c53
10.1093/ibd/izab114
Scopus Count
Related articles
- Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey.
- Authors: Crispino F, Brinch D, Carrozza L, Cappello M
- Issue date: 2021 Oct 20
- SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement.
- Authors: Alexander JL, Moran GW, Gaya DR, Raine T, Hart A, Kennedy NA, Lindsay JO, MacDonald J, Segal JP, Sebastian S, Selinger CP, Parkes M, Smith PJ, Dhar A, Subramanian S, Arasaradnam R, Lamb CA, Ahmad T, Lees CW, Dobson L, Wakeman R, Iqbal TH, Arnott I, Powell N, Inflammatory Bowel Disease section of the British Society of Gastroenterology and the the Inflammatory Bowel Disease Clinical Research Group.
- Issue date: 2021 Mar
- SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.
- Authors: Siegel CA, Melmed GY, McGovern DP, Rai V, Krammer F, Rubin DT, Abreu MT, Dubinsky MC, International Organization for the Study of Inflammatory Bowel Disease (IOIBD)., International Organization for the Study of Inflammatory Bowel Diseases (IOIBD).
- Issue date: 2021 Apr
- SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.
- Authors: Walldorf J, von Arnim U, Schmelz R, Riesner-Wehner A, Michl P, Grunert PC, Stallmach A, Teich N, Reuken PA
- Issue date: 2021 Oct 20
- [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
- Authors: Lee YJ, Kim SE, Park YE, Chang JY, Song HJ, Kim DH, Yang YJ, Kim BC, Lee JG, Yang HC, Choi M, Myung SJ, Clinical Practice Guideline Committee of the Korean Association for the Study of the Intestinal Diseases.
- Issue date: 2021 Aug 25